Press
Releases

Press Releases

February 19, 2020
Altimmune to Present at the Cowen 40th Annual Health Care Conference
GAITHERSBURG, Md. , Feb. 19, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Vipin K. Garg , Ph.D., President and Chief Executive Officer will present at the Cowen 40 th Annual Health Care Conference in Boston on Monday, March
February 4, 2020
Altimmune to Present at Upcoming Investor and Scientific Conferences
GAITHERSBURG, Md. , Feb. 04, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that management will present at the following conferences during the months of February:     2020 BIO CEO & Investor Conference Date:    Monday, February
January 7, 2020
Altimmune to Present at the 2020 NASH-TAG Conference
GAITHERSBURG, Md. , Jan. 07, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced an oral presentation at the 2020 NASH-TAG Conference being held on January 9-11, 2020 in Park City, Utah.  Details for the oral presentation are as
 

Investor Contact

Ashley Robinson
LifeSci Advisors, LLC

Email: arr@lifesciadvisors.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe